通过激活MYC信号传递,PRMT6促进结直肠癌的进展
Xin Zhang1, Mingxin Jin1, Yali Chu1
1Department of General Surgery, Qilu Hospital of Shandong University, 107 West Wenhua Road, JiNan, 250012, China.
Journal of translational medicine
|January 17, 2025
概括
蛋白质氨酸甲基转移酶6 (PRMT6) 通过稳定c-MYC驱动结直肠癌 (CRC) 的进展. 向PRMT6为CRC患者提供了潜在的新治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 结肠直肠癌 (CRC) 由于发病率和死亡率高,对全球健康造成了重大负担.
- 了解驱动CRC进展的分子机制对于开发有效治疗方法至关重要.
研究的目的:
- 调查蛋白质氨酸甲基转移酶6 (PRMT6) 作为结直肠癌中的瘤基因的作用.
- 阐明PRMT6影响瘤进展和患者存活的机制.
主要方法:
- 在CRC组织中分析PRMT6表达和与患者生存数据的相关性.
- 在体外功能测试 (增殖,迁移,入侵) 评估PRMT6对CRC细胞的影响.
- 机制研究涉及通过单甲基化和无化试验稳定c-MYC.
- 使用异种移植模型进行体内验证,以评估PRMT6对瘤生长的影响.
主要成果:
- 在CRC组织中,PRMT6显著过度表达,并与较差的患者结局有关.
- PRMT6促进CRC细胞的增殖,迁移和入侵.
- PRMT6通过氨酸371单甲基化稳定c-MYC,抑制其降解.
- 在体内,PRMT6的淘汰会降低瘤生长和c-MYC水平.
结论:
- 通过增强c-MYC稳定性和促进瘤进展,PRMT6作为CRC中的瘤基因起作用.
- PRMT6是结直肠癌治疗的潜在治疗标.
相关概念视频
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Induced Pluripotent Stem Cells
3.9K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
3.9K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
MAPK Signaling Cascades
5.1K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.1K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K


